Your institution may have access to this item. Find your institution then sign in to continue.
Title
Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients.
Authors
Bartolucci, P; Ramanoelina, J; Cohen, P; Mahr, A; Godmer, P; Le Hello, C; Guillevin, L
Abstract
Evidence indicates that tumour necrosis factor (TNF) is a major agent in the pathogenesis of vasculitis. We studied the short-term effect of anti-TNF-alpha antibody in systemic vasculitis patients refractory to steroids and immunosuppressive agents.